Effector Therapeutics Stock Price, News & Analysis
Company Description
Effector Therapeutics (OTC Link: EFTR) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $611.6K, ranking #7,081 among all listed U.S. companies by market cap.
EFTR stock has gained 0.0% over the past year. Shares last traded at $0.0002.
On a trailing twelve-month basis, Effector Therapeutics reported revenue of $0 with net income of -$35.8M and diluted earnings per share of $-16.37.
This page provides a comprehensive overview of EFTR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Effector Therapeutics (EFTR) stock last traded at $0.0002. At a market capitalization of $611.6K, EFTR is classified as a micro-cap stock with approximately 4.7M shares outstanding.
Latest News
Effector Therapeutics has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 9 with negative movement. Key topics include clinical trial, earnings, conferences, offering. View all EFTR news →
SEC Filings
Financial Highlights
operating income reached -$33.8M, and net income was -$35.8M. Diluted earnings per share stood at $-16.37. The company generated -$29.6M in operating cash flow. With a current ratio of 0.77, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Effector Therapeutics (EFTR) currently stands at 57.2 thousand shares, representing 1.2% of the float. Over the past 12 months, short interest has increased by 898.6%. This relatively low short interest suggests limited bearish sentiment. With 76.6 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Effector Therapeutics (EFTR) currently stands at 76.6 days, down 89.4% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 655% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 723.7 days.
EFTR Company Profile & Sector Positioning
Effector Therapeutics (EFTR) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the OTC Link.
Investors comparing EFTR often look at related companies in the same sector, including Innoveren Scientific Inc (IVRN), Gritstone Bio Inc (GRTSQ), Eloxx Pharmaceut (ELOX), Ampio Pharma (AMPE), and Oncotelic Therapeutics Inc (OTLC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EFTR's relative position within its industry.